Skip to main content
Journal cover image

Successful treatment of cutaneous Acanthamoeba castellanii infection with miltefosine in a patient with chronic lymphocytic leukaemia on ibrutinib.

Publication ,  Journal Article
Teh, JSK; Tam, PCK; Badenoch, PR; Adamson, PJ; Brennan, C; Marshman, G; Gordon, DL
Published in: J Antimicrob Chemother
February 2, 2022

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Antimicrob Chemother

DOI

EISSN

1460-2091

Publication Date

February 2, 2022

Volume

77

Issue

2

Start / End Page

539 / 541

Location

England

Related Subject Headings

  • Piperidines
  • Phosphorylcholine
  • Microbiology
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Humans
  • Adenine
  • Acanthamoeba castellanii
  • 3214 Pharmacology and pharmaceutical sciences
  • 3202 Clinical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Teh, J. S. K., Tam, P. C. K., Badenoch, P. R., Adamson, P. J., Brennan, C., Marshman, G., & Gordon, D. L. (2022). Successful treatment of cutaneous Acanthamoeba castellanii infection with miltefosine in a patient with chronic lymphocytic leukaemia on ibrutinib. J Antimicrob Chemother, 77(2), 539–541. https://doi.org/10.1093/jac/dkab397
Teh, Joanne S. K., Patrick C. K. Tam, Paul R. Badenoch, Penelope J. Adamson, Catriona Brennan, Gillian Marshman, and David L. Gordon. “Successful treatment of cutaneous Acanthamoeba castellanii infection with miltefosine in a patient with chronic lymphocytic leukaemia on ibrutinib.J Antimicrob Chemother 77, no. 2 (February 2, 2022): 539–41. https://doi.org/10.1093/jac/dkab397.
Teh JSK, Tam PCK, Badenoch PR, Adamson PJ, Brennan C, Marshman G, et al. Successful treatment of cutaneous Acanthamoeba castellanii infection with miltefosine in a patient with chronic lymphocytic leukaemia on ibrutinib. J Antimicrob Chemother. 2022 Feb 2;77(2):539–41.
Teh, Joanne S. K., et al. “Successful treatment of cutaneous Acanthamoeba castellanii infection with miltefosine in a patient with chronic lymphocytic leukaemia on ibrutinib.J Antimicrob Chemother, vol. 77, no. 2, Feb. 2022, pp. 539–41. Pubmed, doi:10.1093/jac/dkab397.
Teh JSK, Tam PCK, Badenoch PR, Adamson PJ, Brennan C, Marshman G, Gordon DL. Successful treatment of cutaneous Acanthamoeba castellanii infection with miltefosine in a patient with chronic lymphocytic leukaemia on ibrutinib. J Antimicrob Chemother. 2022 Feb 2;77(2):539–541.
Journal cover image

Published In

J Antimicrob Chemother

DOI

EISSN

1460-2091

Publication Date

February 2, 2022

Volume

77

Issue

2

Start / End Page

539 / 541

Location

England

Related Subject Headings

  • Piperidines
  • Phosphorylcholine
  • Microbiology
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Humans
  • Adenine
  • Acanthamoeba castellanii
  • 3214 Pharmacology and pharmaceutical sciences
  • 3202 Clinical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences